ADITXT INC (ADTX)
US0070256047 - Common Stock
Overall ADTX gets a fundamental rating of 1 out of 10. We evaluated ADTX against 588 industry peers in the Biotechnology industry. ADTX may be in some trouble as it scores bad on both profitability and health. ADTX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ADTX has reported negative net income.
ADTX had a negative operating cash flow in the past year.
In the past 5 years ADTX always reported negative net income.
In the past 5 years ADTX always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -359.68%, ADTX is not doing good in the industry: 95.21% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -359.68% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-201.88%
ROA(5y)-2041.13%
ROE(3y)-356.44%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ADTX's Gross Margin of 15.58% is fine compared to the rest of the industry. ADTX outperforms 75.51% of its industry peers.
The Profit Margin and Operating Margin are not available for ADTX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 15.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ADTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ADTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -31.40, we must say that ADTX is in the distress zone and has some risk of bankruptcy.
ADTX's Altman-Z score of -31.40 is on the low side compared to the rest of the industry. ADTX is outperformed by 90.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -31.4 |
ROIC/WACCN/A
WACC41.68%
2.3 Liquidity
A Current Ratio of 0.30 indicates that ADTX may have some problems paying its short term obligations.
With a Current ratio value of 0.30, ADTX is not doing good in the industry: 96.75% of the companies in the same industry are doing better.
ADTX has a Quick Ratio of 0.30. This is a bad value and indicates that ADTX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.23, ADTX is not doing good in the industry: 98.12% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.3 | ||
| Quick Ratio | 0.23 |
3. Growth
3.1 Past
ADTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.18%, which is quite impressive.
Looking at the last year, ADTX shows a very negative growth in Revenue. The Revenue has decreased by -11.24% in the last year.
EPS 1Y (TTM)77.18%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q77.23%
Revenue 1Y (TTM)-11.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q-61.1%
3.2 Future
Based on estimates for the next years, ADTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.98% on average per year.
ADTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 155.02% yearly.
EPS Next Y95.36%
EPS Next 2Y40.98%
EPS Next 3Y19.98%
EPS Next 5YN/A
Revenue Next Year-32.41%
Revenue Next 2Y-0.78%
Revenue Next 3Y155.02%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
ADTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ADTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ADTX's earnings are expected to grow with 19.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.98%
EPS Next 3Y19.98%
5. Dividend
5.1 Amount
No dividends for ADTX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ADITXT INC
NASDAQ:ADTX (4/24/2024, 7:00:00 PM)
After market: 2.32 -0.05 (-2.11%)2.37
+0.1 (+4.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.04M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -359.68% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 15.58% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.3 | ||
| Quick Ratio | 0.23 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)77.18%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y95.36%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.24%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y